Clinical Trial Update: Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

View source ↗

Summary

Clinical trial evaluating NGAL in acute kidney injury within symptomatic heart failure has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Kidney Injury

Drugs mentioned

• NGAL evaluation study (Neutrophil Gelatinase-Associated Lipocalin)

Snippet

Sponsor: Alere San Diego | Conditions: Acute Decompensated Heart Failure, Acute Kidney Injury | Status: COMPLETED | Results posted: 2018-02-19